Medium-Chain Triglyceride (MCT) Content of Adult Enteral Tube Feeding Formulas and Clinical Outcomes. A Systematic Review

Available data on the effect of lipid composition of enteral formulas on clinical outcomes are controversial. The present systematic review was performed in order to verify whether the presence of specific lipidic substrates, namely medium-chain triglycerides (MCT), in enteral tube feeding formulas...

Full description

Bibliographic Details
Main Authors: Maurizio Muscaritoli, Lorenzo Pradelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Nutrition
Subjects:
MCT
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2021.697529/full
id doaj-37d9af5b4cb74485a15d6d4397bf35fb
record_format Article
spelling doaj-37d9af5b4cb74485a15d6d4397bf35fb2021-08-02T04:49:48ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2021-08-01810.3389/fnut.2021.697529697529Medium-Chain Triglyceride (MCT) Content of Adult Enteral Tube Feeding Formulas and Clinical Outcomes. A Systematic ReviewMaurizio Muscaritoli0Lorenzo Pradelli1Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, ItalyAdRes-Health Economics and Outcome Research, Turin, ItalyAvailable data on the effect of lipid composition of enteral formulas on clinical outcomes are controversial. The present systematic review was performed in order to verify whether the presence of specific lipidic substrates, namely medium-chain triglycerides (MCT), in enteral tube feeding formulas is associated to measurable clinical benefits in patients receiving enteral nutrition in different clinical settings, including home enteral nutrition (HEN). The results of this systematic review highlight a lack of robust evidence supporting the use of specific types of lipids in standard or disease-specific formulas. Evidence exists, however, that MCT-containing formulas are safe and well-tolerated. Further, well-designed, adequately powered, randomized controlled trials would be needed in order to assess the superiority of MCT- containing enteral formulas over other standard or disease-specific commercially available enteral products.https://www.frontiersin.org/articles/10.3389/fnut.2021.697529/fulllipid compositionmedium-chain triglyceridesMCTclinical outcomesenteral nutrition: enteral tube feeding formulas
collection DOAJ
language English
format Article
sources DOAJ
author Maurizio Muscaritoli
Lorenzo Pradelli
spellingShingle Maurizio Muscaritoli
Lorenzo Pradelli
Medium-Chain Triglyceride (MCT) Content of Adult Enteral Tube Feeding Formulas and Clinical Outcomes. A Systematic Review
Frontiers in Nutrition
lipid composition
medium-chain triglycerides
MCT
clinical outcomes
enteral nutrition: enteral tube feeding formulas
author_facet Maurizio Muscaritoli
Lorenzo Pradelli
author_sort Maurizio Muscaritoli
title Medium-Chain Triglyceride (MCT) Content of Adult Enteral Tube Feeding Formulas and Clinical Outcomes. A Systematic Review
title_short Medium-Chain Triglyceride (MCT) Content of Adult Enteral Tube Feeding Formulas and Clinical Outcomes. A Systematic Review
title_full Medium-Chain Triglyceride (MCT) Content of Adult Enteral Tube Feeding Formulas and Clinical Outcomes. A Systematic Review
title_fullStr Medium-Chain Triglyceride (MCT) Content of Adult Enteral Tube Feeding Formulas and Clinical Outcomes. A Systematic Review
title_full_unstemmed Medium-Chain Triglyceride (MCT) Content of Adult Enteral Tube Feeding Formulas and Clinical Outcomes. A Systematic Review
title_sort medium-chain triglyceride (mct) content of adult enteral tube feeding formulas and clinical outcomes. a systematic review
publisher Frontiers Media S.A.
series Frontiers in Nutrition
issn 2296-861X
publishDate 2021-08-01
description Available data on the effect of lipid composition of enteral formulas on clinical outcomes are controversial. The present systematic review was performed in order to verify whether the presence of specific lipidic substrates, namely medium-chain triglycerides (MCT), in enteral tube feeding formulas is associated to measurable clinical benefits in patients receiving enteral nutrition in different clinical settings, including home enteral nutrition (HEN). The results of this systematic review highlight a lack of robust evidence supporting the use of specific types of lipids in standard or disease-specific formulas. Evidence exists, however, that MCT-containing formulas are safe and well-tolerated. Further, well-designed, adequately powered, randomized controlled trials would be needed in order to assess the superiority of MCT- containing enteral formulas over other standard or disease-specific commercially available enteral products.
topic lipid composition
medium-chain triglycerides
MCT
clinical outcomes
enteral nutrition: enteral tube feeding formulas
url https://www.frontiersin.org/articles/10.3389/fnut.2021.697529/full
work_keys_str_mv AT mauriziomuscaritoli mediumchaintriglyceridemctcontentofadultenteraltubefeedingformulasandclinicaloutcomesasystematicreview
AT lorenzopradelli mediumchaintriglyceridemctcontentofadultenteraltubefeedingformulasandclinicaloutcomesasystematicreview
_version_ 1721241913898565632